# BioMap

Robin Li’s IPO Harvest: Can a Trio of Spin-offs Validate Baidu’s AI Bet?

Baidu is orchestrating a series of Hong Kong IPOs for its AI chip, biotech, and video streaming subsidiaries to unlock value from its 'All in AI' strategy. While the spin-offs showcase technical depth, they face significant headwinds from market skepticism, declining legacy revenues, and a sustained internal talent drain.

SoBiz2026年4月7日 11:28

#Baidu#Robin Li#Kunlun Chip

Charming vintage flatlay with a typewriter, coffee mug, flowers, and rings on a wooden surface.

Business

The Great Unbundling: Robin Li’s AI Empire Faces a Trial by Capital

Baidu founder Robin Li is preparing a triple IPO for Kunlun Xi, BioMap, and iQIYI in Hong Kong as part of a major 'All in AI' monetization push. Despite the move, Baidu faces a significant market valuation slump and persistent skepticism regarding its ability to retain talent and convert technical prowess into standalone commercial success.

SoBiz2026年4月7日 04:58

#Baidu#Robin Li#Kunlun Chip